Revolution Medicines, Inc. (NASDAQ:RVMD) Q3 2025 Earnings Call Transcript November 5, 2025
Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-1.61 EPS, expectations were $-1.39.
Operator: Good day, and thank you for standing by. Welcome to the Revolution Medicines Q3 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Ryan Asay,...
